Hemozoin biocrystallization process

Hemozoin biocrystallization is a critical detoxification pathway utilized by intraerythrocytic parasites, such as Plasmodium falciparum, to neutralize the toxic byproducts of hemoglobin digestion (Sullivan, 2002). During their life cycle in human red blood cells, these parasites consume host hemoglobin, releasing large quantities of free ferriprotoporphyrin IX (heme) (Egan, 2008). Because free heme is highly toxic and can cause oxidative damage to parasite membranes and proteins, the parasite sequesters it into an insoluble, chemically inert crystalline form called hemozoin (Weissbuch & Leiserowitz, 2008). This biomineralization process occurs within the parasite's acidic food vacuole and is essential for its survival and proliferation (Coronado et al., 2014). This pathway serves as the primary target for several classes of antimalarial drugs, most notably the quinolines and related compounds (Egan, 2008). Drugs like chloroquine and quinine interfere with the crystallization process by binding to heme monomers or the growing faces of the hemozoin crystals, preventing further detoxification (Weissbuch & Leiserowitz, 2008). The subsequent accumulation of free heme leads to the generation of reactive oxygen species and the eventual lysis of the parasite (Sullivan, 2002). Despite the historical success of targeting this process, the emergence of resistance mechanisms, such as the evolution of the Plasmodium falciparum chloroquine resistance transporter (PfCRT), remains a significant challenge in global malaria control (Coronado et al., 2014).

Other names

Heme detoxification pathwayHemozoin formationMalaria pigment crystallizationFerriprotoporphyrin IX polymerization

Inhibition of the conversion of toxic free heme (ferriprotoporphyrin IX) into insoluble hemozoin crystals, leading to parasite death via heme-induced oxidative damage (Sullivan, 2002; Egan, 2008).